Physician profile
Michele A Evans
NPI 1760804546
$7,233.61
in general payments reported to CMS, 2019-2025
30 companies · $1,299 in 2025
The $1,299 reported for 2025 was more than what 88% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $278 · 2022: $606 · 2023: $2,719 · 2024: $2,331 · 2025: $1,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,249 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,248.95 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $987.26 | 2023-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $861.95 | 2021-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $792.40 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $492.92 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $409.00 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $393.94 | 2022-2025 | Glassia |
| Harmony Biosciences LLC | $391.59 | 2022-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $377.46 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $297.50 | 2022-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $287.24 | 2023-2025 | Ofev, Stiolto Respimat |
| Mylan Specialty L.P. | $255.53 | 2021-2024 | Yupelri |
| Amgen INC. | $220.16 | 2022-2025 | Tezspire, Tavneos |
| United Therapeutics Corporation | $190.77 | 2022-2025 | Tyvaso, Tyvaso |
| Mallinckrodt Hospital Products INC. | $180.60 | 2022-2024 | Acthar |
| Paratek Pharmaceuticals, INC. | $165.21 | 2022-2024 | Nuzyra |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $164.39 | 2021-2024 | Xolair |
| Merz North America, INC. | $135.56 | 2025 | |
| Ethicon US, LLC | $99.73 | 2021 | |
| Lundbeck LLC | $94.97 | 2022 | |
| Axsome Therapeutics, INC. | $90.88 | 2023-2025 | Sunosi |
| Baxter Healthcare | $63.10 | 2024 | Hillrom - Monarch Airway Clearance System |
| Lilly USA, LLC | $55.38 | 2025 | Zepbound |
| Actelion Pharmaceuticals US, INC. | $40.15 | 2024 | Opsumit, Uptravi |
| Pharming Healthcare, INC. | $39.15 | 2023 | Ruconest |
| Electromed, INC. | $34.24 | 2024 | Smartvest |
| Teva Pharmaceuticals USA, INC. | $31.22 | 2022-2023 | Airduo Digihaler |
| Philips North America LLC | $30.04 | 2022-2024 | (Ak6) Vest Therapy |
| Resmed Corp | $17.43 | 2024 | |
| Merck Sharp & Dohme LLC | $17.33 | 2023 | Belsomra |
| Ani Pharmaceuticals, INC. | $16.51 | 2024 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.